Gavel on flag Critics say thelegislation goes too far in limiting drugmakers’ discretion to setprices and doesn’t do enough to help consumers. (Photo:Shutterstock)

A bipartisan Senate bill would yield $100 billion in savings onprescription-drug spending over a decade, twoof its sponsors said, in part by penalizing pharmaceuticalcompanies for raising prices faster than the rate of inflation.

The legislation, which has the backing of the White House,contains several proposals designed to reduce government outlays inMedicare and Medicaid. It also seeks to limit what patients whohave Medicare drug plans would have to spend out of their ownpockets on prescriptions.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.